After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more

StreetInsider2021-10-27

After-Hours Stock Movers: Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

SanWangtikup
2021-10-27
SanWangtikup
[Smile]
- Kelvin_Qiu:
  [强]
ming22
2021-10-27
ming22
$Tenable Holdings Inc.(TENB)$🚀🚀
skylander
2021-10-27
skylander
Like like pls
- PickleT68:
  Ok like pls
HENRYCSC
2021-10-27
HENRYCSC
Like pls
- 小虎一飞冲天:
  👍🏼
KYHBKO
2021-10-27
KYHBKO
$Alphabet(GOOG)$ price drops despite having a great earnings. can consider to take up positions as the stock bottoms up over the next few days
- 滚股怪:
  D id
Kong06
2021-10-27
Kong06
👍🏻

发表看法

227

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2178288807?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-27 07:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2178288807","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HOOD","symbol_name":"Robinhood","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","article_id":"2178288807","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","pubTimestamp":1635291594,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"HOOD":"Robinhood","QNETCN":"纳斯达克中美互联网老虎指数","TWTR":"Twitter","JNPR":"瞻博网络","TENB":"Tenable Holdings Inc."},"translate_title":"下班后股票搬运工:Cortexyme、Tendable、QuantumScape、Juniper Networks等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRTX":0.9,"HOOD":0.9,"JNPR":0.9,"QNETCN":0.9,"TENB":0.9,"TWTR":0.9,"ZIOP":0.9},"content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":855080325,"gmtCreate":1635313756237,"gmtModify":1635313756446,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855080325","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6342685,"gmtCreate":1635320088433,"gmtModify":1635320088544,"authorId":3581638828642415,"author":{"id":3581638828642415,"authorId":3581638828642415,"name":"Kelvin_Qiu","avatar":"https://static.tigerbbs.com/58df4d9e030a9766be7d0b65f5e798af","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855080325,"type":1,"supId":0,"prevId":0,"content":"[强]","text":"[强]","html":"[强]"}],"langContent":"CN"},{"id":855035653,"gmtCreate":1635312079026,"gmtModify":1635312079308,"author":{"id":"3571044771112848","authorId":"3571044771112848","name":"ming22","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"<a href=\"https://laohu8.com/S/TENB\">$Tenable Holdings Inc.(TENB)$</a>🚀🚀","listText":"<a href=\"https://laohu8.com/S/TENB\">$Tenable Holdings Inc.(TENB)$</a>🚀🚀","text":"$Tenable Holdings Inc.(TENB)$🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855035653","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":855031244,"gmtCreate":1635311514403,"gmtModify":1635311514752,"author":{"id":"4087989241523320","authorId":"4087989241523320","name":"skylander","avatar":"https://static.tigerbbs.com/1c70a5b34449eb6137e74ae1fefb2ea0","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like like pls","listText":"Like like pls","text":"Like like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855031244","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6341904,"gmtCreate":1635311598875,"gmtModify":1635311598909,"authorId":3581915827887523,"author":{"id":3581915827887523,"authorId":3581915827887523,"name":"PickleT68","avatar":"https://static.tigerbbs.com/8fce28b8d12bdeb2997c5098f8b8e413","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855031244,"type":1,"supId":0,"prevId":0,"content":"Ok like pls","text":"Ok like pls","html":"Ok like pls"}],"langContent":"CN"},{"id":852717677,"gmtCreate":1635302823712,"gmtModify":1635302823945,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852717677","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6340760,"gmtCreate":1635303043331,"gmtModify":1635303043436,"authorId":3582098623642517,"author":{"id":3582098623642517,"authorId":3582098623642517,"name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852717677,"type":1,"supId":0,"prevId":0,"content":"👍🏼","text":"👍🏼","html":"👍🏼"}],"langContent":"CN"},{"id":852735964,"gmtCreate":1635301577982,"gmtModify":1635301577982,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"<a href=\"https://laohu8.com/S/GOOG\">$Alphabet(GOOG)$</a> price drops despite having a great earnings. can consider to take up positions as the stock bottoms up over the next few days","listText":"<a href=\"https://laohu8.com/S/GOOG\">$Alphabet(GOOG)$</a> price drops despite having a great earnings. can consider to take up positions as the stock bottoms up over the next few days","text":"$Alphabet(GOOG)$ price drops despite having a great earnings. can consider to take up positions as the stock bottoms up over the next few days","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852735964","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6340912,"gmtCreate":1635303656177,"gmtModify":1635303656229,"authorId":4091089381144950,"author":{"id":4091089381144950,"authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852735964,"type":1,"supId":0,"prevId":0,"content":"D id","text":"D id","html":"D id"}],"langContent":"CN"},{"id":852475081,"gmtCreate":1635299939287,"gmtModify":1635300012582,"author":{"id":"3581903045598734","authorId":"3581903045598734","name":"Kong06","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"👍🏻&nbsp;","listText":"👍🏻&nbsp;","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852475081","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc.  70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","JNPR":"瞻博网络","HOOD":"Robinhood","TENB":"Tenable Holdings Inc.","TWTR":"Twitter"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":227,"commentSize":22,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2178288807"}